Juan Armando Chiossone Kerdel, MD
Otolaryngology · Plantation, FLNPI 1457818965
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,659 of the $27,334 with a category attached, or 90.2%. Advanced Bionics, LLC accounts for 90.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $22,768 and has fallen 98.8% since, to $279 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $854.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Bionics, LLC$25K
- Iotamotion, Inc.$1K
- Cochlear Americas$550
- Stryker$438
- Johnson & Johnson$142
- Med-el Corporation$69
- plus $46 from 2 others
What the payments were for
- Consulting fees$24,65990%
- Travel & lodging$1,1964%
- Food & beverage$1,4795%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Advanced Bionics, LLC | 10 | $24,832 |
| Iotamotion, Inc. | 2 | $1,257 |
| Cochlear Americas | 5 | $550 |
| Stryker | 10 | $438 |
| Johnson & Johnson | 2 | $142 |
| Med-el Corporation | 1 | $69 |
| UCB, Inc. | 1 | $29 |
| GSK | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,334 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 29 | $702 |
| Ofloxacin | 24 | $399 |
| Mometasone Furoate | 18 | $239 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 14 | $137 |
| Ibuprofen | 18 | $95 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $67 |
| Prednisone | 16 | $37 |
| Hydrochlorothiazide | 22 | $23 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Plantation
- Camysha WrightPlantation$38K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.